BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17727807)

  • 1. Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.
    Couvreur B; Letellier C; Olivier F; Dehan P; Elouahabi A; Vandenbranden M; Ruysschaert JM; Hamers C; Pastoret PP; Kerkhofs P
    Vet Res; 2007; 38(6):819-34. PubMed ID: 17727807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.
    R El-Attar LM; Thomas C; Luke J; A Williams J; Brownlie J
    Vaccine; 2015 Jul; 33(32):4004-12. PubMed ID: 26079613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.
    Liang R; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Aug; 25(32):5994-6006. PubMed ID: 17597267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocompetent truncated E2 glycoprotein of bovine viral diarrhea virus (BVDV) expressed in Nicotiana tabacum plants: a candidate antigen for new generation of veterinary vaccines.
    Nelson G; Marconi P; Periolo O; La Torre J; Alvarez MA
    Vaccine; 2012 Jun; 30(30):4499-504. PubMed ID: 22554468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats.
    Baxi MK; Deregt D; Robertson J; Babiuk LA; Schlapp T; Tikoo SK
    Virology; 2000 Dec; 278(1):234-43. PubMed ID: 11112498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncated E2 of bovine viral diarrhea virus (BVDV) expressed in Drosophila melanogaster cells: a candidate antigen for a BVDV ELISA.
    Marzocca MP; Seki C; Giambiagi SM; Robiolo B; Schauer R; Dus Santos MJ; Scodeller EA; La Torre JL; Wigdorovitz A; Grigera PR
    J Virol Methods; 2007 Sep; 144(1-2):49-56. PubMed ID: 17512989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
    Hamers C; Di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
    Vet J; 2002 Jan; 163(1):61-7. PubMed ID: 11749137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.
    Young NJ; Thomas CJ; Thompson I; Collins ME; Brownlie J
    Prev Vet Med; 2005 Nov; 72(1-2):115-20; discussion 215-9. PubMed ID: 16169103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by
    Wang Y; Feng B; Niu C; Jia S; Sun C; Wang Z; Jiang Y; Cui W; Wang L; Xu Y
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of virus-neutralizing antibodies by immunization with Rachiplusia nu per os infected with a recombinant baculovirus expressing the E2 glycoprotein of bovine viral diarrhea virus.
    Ferrer F; Zoth SC; Calamante G; Taboga O
    J Virol Methods; 2007 Dec; 146(1-2):424-7. PubMed ID: 17905447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the E2 envelope glycoprotein of bovine viral diarrhoea virus (BVDV) elicits virus-type specific neutralising antibodies.
    Toth RL; Nettleton PF; McCrae MA
    Vet Microbiol; 1999 Mar; 65(2):87-101. PubMed ID: 10078593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus.
    Thomas C; Young NJ; Heaney J; Collins ME; Brownlie J
    Vaccine; 2009 Apr; 27(17):2387-93. PubMed ID: 19428855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the induction of NS3 specific BVDV antibodies using a commercial inactivated BVDV vaccine in immunization and challenge trials.
    Makoschey B; Sonnemans D; Bielsa JM; Franken P; Mars M; Santos L; Alvarez M
    Vaccine; 2007 Aug; 25(32):6140-5. PubMed ID: 17336433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
    Xue W; Mattick D; Smith L; Umbaugh J; Trigo E
    Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge.
    Nobiron I; Thompson I; Brownlie J; Collins ME
    Vaccine; 2003 May; 21(17-18):2082-92. PubMed ID: 12706698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant E2 glycoprotein of bovine viral diarrhea virus induces a solid humoral neutralizing immune response but fails to confer total protection in cattle.
    Chimeno Zoth S; Leunda MR; Odeón A; Taboga O
    Braz J Med Biol Res; 2007 Jun; 40(6):813-8. PubMed ID: 17581680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to bovine viral diarrhea virus: a constantly changing picture.
    Chase CC; Elmowalid G; Yousif AA
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):95-114. PubMed ID: 15062477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Bovine Viral Diarrhea Virus Envelope Glycoprotein E2 in Yeast Pichia pastoris and its Application to an ELISA for Detection of BVDV Neutralizing Antibodies in Cattle.
    Behera SP; Mishra N; Nema RK; Pandey PD; Kalaiyarasu S; Rajukumar K; Prakash A
    J Immunoassay Immunochem; 2015; 36(6):639-54. PubMed ID: 25837831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.